Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2019-12-01 (6 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: NONANCOURT (27320), Eure
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE NONANCOURT : revenue, balance sheet and financial ratios
PHARMACIE DE NONANCOURT is a French company
founded 6 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in NONANCOURT (27320),
this company of category PME
shows in 2025 a net income positive of 54 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE NONANCOURT (SIREN 878716968)
Indicator
2025
2024
2023
2022
2021
2020
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
54 151 €
52 558 €
63 930 €
81 960 €
78 899 €
22 517 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE NONANCOURT generates positive net income of 54 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2025: 23 k€ -> 54 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
54 151 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 43%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 53%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
43.152%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
53.104%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE NONANCOURT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
2024
2025
Debt ratio
706.853
238.433
149.303
111.569
70.389
43.152
Financial autonomy
9.707
22.853
33.028
36.424
43.801
53.104
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
43.152025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good-16 pts over 3 years
In 2025, the debt ratio of PHARMACIE DE NONANCOURT (43.15) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
53.1%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average+15 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DE NONANCOURT (53.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 194.15. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
194.152
Liquidity indicators evolution PHARMACIE DE NONANCOURT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2020
2021
2022
2023
2024
2025
Liquidity ratio
192.53
203.893
256.911
181.348
180.554
194.152
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
194.152025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good+8 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE NONANCOURT (194.15) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DE NONANCOURT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE NONANCOURT is estimated at
860 195 €
(range 583 732€ - 1 349 764€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
583k€860k€1349k€
860 195 €Range: 583 732€ - 1 349 764€
NAF 5 année 2025
Valuation method used
Net Income Multiple
54 151 €
×
15.9x
=860 195 €
Range: 583 732€ - 1 349 765€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE NONANCOURT with other companies in the same sector:
Frequently asked questions about PHARMACIE DE NONANCOURT
What is the revenue of PHARMACIE DE NONANCOURT ?
The revenue of PHARMACIE DE NONANCOURT is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE NONANCOURT profitable?
Yes, PHARMACIE DE NONANCOURT generated a net profit of 54 k€ in 2025.
Where is the headquarters of PHARMACIE DE NONANCOURT ?
The headquarters of PHARMACIE DE NONANCOURT is located in NONANCOURT (27320), in the department Eure.
Where to find the tax return of PHARMACIE DE NONANCOURT ?
The tax return of PHARMACIE DE NONANCOURT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE NONANCOURT operate?
PHARMACIE DE NONANCOURT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart